InvestorsHub Logo
Followers 2
Posts 436
Boards Moderated 0
Alias Born 01/14/2014

Re: None

Thursday, 06/30/2016 10:54:34 AM

Thursday, June 30, 2016 10:54:34 AM

Post# of 807
Novartis will pay an upfront fee of $150 million to Xencor along with potential milestone payments totalling up to $2.41 billion (as and when milestones are achieved)

HTTP://finance.yahoo.com/news/xencor-stock-cancer-drugs-partnership-222010958.html

XmAb antibodies. Not sure how they compare with the 5T4 antibody? It would be nice if they fancied CarT 5T4

HTTP://www.dnavaccine.com/2016/06/cancer-vaccines-conference-in-london/